Logotype for AT & S Austria Technologie & Systemtechnik Aktiengesellschaft

AT & S Austria Technologie & Systemtechnik (ATS) Q2 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for AT & S Austria Technologie & Systemtechnik Aktiengesellschaft

Q2 2025 earnings summary

15 May, 2026

Executive summary

  • Revenue for H1 2024/25 declined 1.7% year-over-year to €799.9 million, with EBITDA down 27% to €157 million and a net loss of €63 million; Q2 revenue was €451 million, up 29% sequentially.

  • Management board transitioned to joint CEO responsibility among three board members after the chairman stepped down; cost optimization and efficiency programs, including workforce reduction, are underway.

  • Installation and qualification of equipment at Kulim and Leoben factories progressing, with production ramp-up delayed to early 2025 due to market conditions.

  • Sale agreement for AT&S Korea (Ansan site) signed for €405 million, expected to close by March 2025, with proceeds to reduce leverage.

  • Market environment remains weak with significant price pressure and overcapacity, leading to a revised FY 2024/25 outlook, but mid-term guidance remains unchanged.

Financial highlights

  • Half-year revenue was €799.9 million, down 1.7% year-over-year, with EBITDA at €157.2 million (down 27.4%) and net loss of €63 million.

  • EBITDA margin at 19.6% (adjusted: 27.9%), EBIT margin at 0.9% (adjusted: 10.0%), and earnings per share at €-1.84.

  • Net CAPEX halved to €254.2 million; operating free cash flow negative at €-344.8 million.

  • Strong sequential growth in Q2 over Q1, driven by seasonality in Electronics Solutions and Microelectronics.

  • Net debt increased by 19% to €1.67 billion, with leverage at 6.7x.

Outlook and guidance

  • FY 2024/25 revenue guidance revised to €1.5–1.6 billion, with adjusted EBITDA margin of 24–26%.

  • Net CAPEX guidance capped at €500 million.

  • Adjustments increased from €88 million to €110 million, reflecting a 1–2 quarter delay in high-volume manufacturing.

  • FY 2026/27 mid-term guidance confirmed: revenue ~€3.0 billion, EBITDA margin 27–32%, ROCE >12%.

  • High-volume production at new plants in Malaysia and Austria delayed, with no revenue contribution expected this year.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more